Nuvation Bio Inc.
NUVB
$4.32
-$0.40-8.48%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 110.14% | 25.99% | -35.38% | 87.24% | -259.90% |
| Total Depreciation and Amortization | 72.90% | 146.12% | 229.63% | 45.90% | 434.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.78% | 26.87% | 114.57% | -97.62% | 107.09% |
| Change in Net Operating Assets | -516.75% | 6.98% | -274.12% | 103.17% | 159.86% |
| Cash from Operations | 111.89% | 35.78% | -70.14% | -29.08% | -171.47% |
| Capital Expenditure | 33.33% | -784.62% | 91.89% | -- | -166.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -180.34% | 68.12% | -430.13% | 153.10% | 616.79% |
| Cash from Investing | -180.54% | 68.20% | -431.85% | 60.11% | 618.40% |
| Total Debt Issued | -- | 100.95% | -- | 2,727.31% | -- |
| Total Debt Repaid | -61.80% | -52.29% | 97.88% | 97.37% | -- |
| Issuance of Common Stock | -16.08% | 632.18% | -66.59% | -36.36% | 5,052.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -91.97% | 995.89% | 132.57% | 6,938.68% | 2,509.52% |
| Foreign Exchange rate Adjustments | -213.91% | -120.05% | 91.37% | -264.10% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -415.77% | 1,046.28% | -3,408.43% | 88,985.78% | 250.56% |